drug
tretinoin
Marketedupdated 3mo agoby Mylan Pharmaceuticals Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 3all catalysts(0)
nothing on the calendar yet
Trials studying tretinoin
- phase2Isotretinoin vs. Doxycycline for Acneiform Rash in Patients Receiving Drugs That Target the MAPK Pathway
- phase1A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris
- phase2A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma
- phase3Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia
- N/AThe Effects of Topical Almond Oil and Tretinoin on Facial Wrinkles
- phase2Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)
- phase2A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001)
- phase4A Companion Treatment Study for Patients With Moderate to Severe Acne Vulgaris
Patent cliff
source: FDA Orange Bookfirst barrier falls
Aug 22, 2038
~12.0 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Aug 22, 2038formulationUS 10653656
- Aug 22, 2038method-of-use (U-2368)US 11324710
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 41m ago
Found something off?
comments(0)
5-min edit window · permanent after that